Century Therapeutics, Inc. (IPSC) Financials

$0.54

north_east
$0.02 (3.27%)
Day's range
$0.5
Day's range
$0.54
$50M$50M$0$0-$50M-$50M-$100M-$100M-$150M-$150M-$200M-$200M-$250M-$250MEarning201920192020202020212021202220222023202320242024-1000%-1000%-2000%-2000%-3000%-3000%-4000%-4000%-5000%-5000%-6000%-6000%-7000%-7000%Profit Margin
Profit Margin
Revenue
Earnings

IPSC Income statement / Annual

Last year (2024), Century Therapeutics, Inc.'s total revenue was $6.59 M, an increase of 194.81% from the previous year. In 2024, Century Therapeutics, Inc.'s net income was -$126.57 M. See Century Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Operating Revenue $6.59 M $2.24 M $5.20 M $0.00 $0.00 $0.00
Cost of Revenue $13.30 M $13.04 M $10.07 M $4.58 M $1.75 M $249,000.00
Gross Profit -$6.72 M -$10.81 M -$4.87 M -$4.58 M -$1.75 M -$249,000.00
Gross Profit Ratio -1.02 -4.84 -0.94 0 0 0
Research and Development Expenses $107.24 M $92.71 M $107.17 M $75.65 M $39.68 M $14.27 M
General & Administrative Expenses $33.16 M $34.71 M $31.86 M $19.24 M $9.50 M $5.77 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $33.16 M $34.71 M $31.86 M $19.24 M $9.50 M $5.77 M
Other Expenses $4.33 M $21.37 M $4.42 M $377,000.00 $704,000.00 $1.21 M
Operating Expenses $144.73 M $148.78 M $139.03 M $94.88 M $49.18 M $20.03 M
Cost And Expenses $144.73 M $148.78 M $139.03 M $94.88 M $49.18 M $20.03 M
Interest Income $13.01 M $12.68 M $2.99 M $898,000.00 $704,000.00 $1.21 M
Interest Expense $0.00 $540,000.00 $1.11 M $1.28 M $381,000.00 $0.00
Depreciation & Amortization $13.30 M $13.04 M $10.07 M $4.58 M $1.75 M $249,000.00
EBITDA -$111.47 M -$121.21 M -$119.34 M -$89.92 M -$51.44 M -$19.78 M
EBITDA Ratio -16.92 -54.23 -22.95 0 0 0
Operating Income Ratio -20.96 -65.57 -25.74 0 0 0
Total Other Income/Expenses Net $13.36 M $11.75 M $2.99 M -$898,000.00 $323,000.00 $1.21 M
Income Before Tax -$124.78 M -$134.79 M -$130.84 M -$95.78 M -$53.58 M -$244.77 M
Income Before Tax Ratio -18.94 -60.31 -25.17 0 0 0
Income Tax Expense $1.79 M $1.88 M $91,000.00 $43,000.00 $1.09 M $1.21 M
Net Income -$126.57 M -$136.67 M -$130.93 M -$95.82 M -$54.66 M -$245.98 M
Net Income Ratio -19.21 -61.15 -25.18 0 0 0
EPS -1.61 -2.3 -2.27 -1.74 -1 -4.49
EPS Diluted -1.61 -2.3 -2.27 -1.74 -1 -4.49
Weighted Average Shares Out $78.65 M $59.31 M $57.76 M $55.01 M $54.82 M $54.82 M
Weighted Average Shares Out Diluted $78.65 M $59.31 M $57.76 M $55.01 M $54.82 M $54.82 M
Link